In conclusion, we are the first team to study the significance of MMP-2, MMP-3, MMP-11 and MMP-26 as new markers of ovarian cancer in comparison not only to HE4 and CA125, but also to the ROMA algorithm. This evidence concerns the gene MMP11 and ovarian cancer.